Literature DB >> 25346630

Monotherapy in newly diagnosed epilepsy: levetiracetam versus standard anticonvulsants.

Mohamad Z Koubeissi.   

Abstract

Entities:  

Year:  2014        PMID： 25346630      PMCID： PMC4189633          DOI： 10.5698/1535-7597-14.5.255

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  9 in total

1.  Improved tolerability and efficacy in epilepsy patients with extended-release carbamazepine.

Authors:  D M Ficker; M Privitera; G Krauss; A Kanner; J L Moore; T Glauser
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

2.  Levetiracetam: more evidence of safety in pregnancy.

Authors:  Mohamad Koubeissi
Journal:  Epilepsy Curr       Date:  2013-11       Impact factor: 7.500

3.  KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.

Authors:  Eugen Trinka; Anthony G Marson; Wim Van Paesschen; Reetta Kälviäinen; Jacqueline Marovac; Benjamin Duncan; Sonja Buyle; Yngve Hallström; Petr Hon; Gian Carlo Muscas; Mark Newton; Heinz-Joachim Meencke; Philip E Smith; Bernd Pohlmann-Eden
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-08-29       Impact factor: 10.154

4.  Early identification of refractory epilepsy.

Authors:  P Kwan; M J Brodie
Journal:  N Engl J Med       Date:  2000-02-03       Impact factor: 91.245

5.  Conversion from delayed-release sodium valproate to extended-release sodium valproate: initial results and long-term follow-up.

Authors:  Paul H McCabe; Nancy C Michel; Cathy D McNew; Erik B Lehman
Journal:  Epilepsy Behav       Date:  2006-05       Impact factor: 2.937

6.  Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy.

Authors:  M J Brodie; E Perucca; P Ryvlin; E Ben-Menachem; H-J Meencke
Journal:  Neurology       Date:  2007-02-06       Impact factor: 9.910

7.  Tolerability and efficacy of oral loading of levetiracetam.

Authors:  M Z Koubeissi; S Amina; I Pita; G K Bergey; M A Werz
Journal:  Neurology       Date:  2008-05-27       Impact factor: 9.910

8.  Patterns of treatment response in newly diagnosed epilepsy.

Authors:  M J Brodie; S J E Barry; G A Bamagous; J D Norrie; P Kwan
Journal:  Neurology       Date:  2012-05-09       Impact factor: 9.910

9.  The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.

Authors:  Anthony G Marson; Asya M Al-Kharusi; Muna Alwaidh; Richard Appleton; Gus A Baker; David W Chadwick; Celia Cramp; Oliver C Cockerell; Paul N Cooper; Julie Doughty; Barbara Eaton; Carrol Gamble; Peter J Goulding; Stephen J L Howell; Adrian Hughes; Margaret Jackson; Ann Jacoby; Mark Kellett; Geoffrey R Lawson; John Paul Leach; Paola Nicolaides; Richard Roberts; Phil Shackley; Jing Shen; David F Smith; Philip E M Smith; Catrin Tudur Smith; Alessandra Vanoli; Paula R Williamson
Journal:  Lancet       Date:  2007-03-24       Impact factor: 79.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.